Conditions: Alcohol Dependence
Keywords: Alcoholic
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 190
Healthy volunteers: no

Brief summary:
H8R-MC-HJAQ is a Phase 2, parallel, double-blind, randomized study comparing LY686017 with placebo in a 12-week trial that includes Medical Management. This study is an outpatient study in which approximately 180 alcohol dependent subjects will be enrolled. Subjects will be randomized in a 1:1 fashion to LY686017 or placebo, and will receive once daily dosing for twelve weeks.

Detailed description:

Arms:
arm 1: None arm 2: None

Interventions: intervention 1: LY686017 intervention 2: Placebo
Intervention descriptions: intervention 1: 50 milligrams (mg) daily by oral route for 12 weeks intervention 2: Daily by oral route for 12 weeks

Protocol document: